KTKatarzyna Terejko

Katarzyna Terejko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katarzyna Terejko has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Φ value analysis underscores strong functional and structural compactness of the GABA A receptor

    by Michał A. Michałowski, Katarzyna Terejko, Michalina Gos, Ilona Iżykowska, Marta M. Czyżewska, Karol Kłopotowski, Przemysław T. Kaczor, Aleksandra Brzóstowicz, Estera Płużek, Monika Migdałek, et al.

    γ-aminobutyric acid type A receptor (GABA A R) is a pentameric ligand-gated ion channel that plays a crucial role in inhibition in the adult brain. Structural and electrophysiological studies have provided numerous insights into the receptor’s functioning but the complete molecular mechanism of GABA A R action remains elusive. Herein, we used high-resolution single-channel recording to analyze point-mutated α 1 β 2 γ 2 receptors and applied so called Φ value (REFER, rate-equilibrium free energy relationship) analysis which allows to infer the order of domains engagement during activation, offering a complementary “dynamic” insight into the receptor’s function. As anticipated, point mutations at the orthosteric binding sites reduced GABA binding affinity, with the magnitude of this effect diminishing progressively with increasing distance from the binding site. On the contrary, mutations located all over the macromolecule’s structure, e.g., in “peripheral top position,” extracellular/transmembrane interface, and channel pore, affected the receptor with a clear tendency to influence entire gating including opening/closing, preactivation, and desensitization with no clear correlation with the distance to the channel gate. Interestingly, the calculated Φ values for the GABA A R showed a relatively narrow range (0.42 to 0.81), suggesting that the conformational transitions are highly synchronized and coordinated by a global network of interactions. This prediction is also in agreement with observation that, typically, single GABA A R residue mutation alters the kinetics of not just one but many (often all) conformational transitions. We thus propose a dictum reflecting modus operandi of the GABA A R: Binding is local and gating is global. In conclusion, our analysis indicates that GABA A R shows particularly strong functional compactness manifested as global gating mechanisms and high allostery.


  • Open Access

    Mutations at the M2 and M3 Transmembrane Helices of the GABAARs α1 and β2 Subunits Affect Primarily Late Gating Transitions Including Opening/Closing and Desensitization

    by Katarzyna Terejko, Michał A. Michałowski, Ilona Iżykowska, Anna Dominik, Aleksandra Brzóstowicz, Jerzy W. Mozrzymas

    GABA type A receptors (GABAARs) belong to the pentameric ligand-gated ion channel (pLGIC) family and play a crucial role in mediating inhibition in the adult mammalian brain. Recently, a major progress in determining the static structure of GABAARs was achieved, although precise molecular scenarios underlying conformational transitions remain unclear. The ligand binding sites (LBSs) are located at the extracellular domain (ECD), very distant from the receptor gate at the channel pore. GABAAR gating is complex, comprising three major categories of transitions: openings/closings, preactivation, and desensitization. Interestingly, mutations at, e.g., the ligand binding site affect not only binding but often also more than one gating category, suggesting that structural determinants for distinct conformational transitions are shared. Gielen and co-workers (2015) proposed that the GABAAR desensitization gate is located at the second and third transmembrane segment. However, studies of our and others’ groups indicated that other parts of the GABAAR macromolecule might be involved in this process. In the present study, we asked how selected point mutations (β2G254V, α1G258V, α1L300V, and β2L296V) at the M2 and M3 transmembrane segments affect gating transitions of the α1β2γ2 GABAAR. Using high resolution macroscopic and single-channel recordings and analysis, we report that these substitutions, besides affecting desensitization, also profoundly altered openings/closings, having some minor effect on preactivation and agonist binding. Thus, the M2 and M3 segments primarily control late gating transitions of the receptor (desensitization, opening/closing), providing a further support for the concept of diffuse gating mechanisms for conformational transitions of GABAAR.


  • Interaction between GABAA receptor α1 and β2 subunits at the N-terminal peripheral regions is crucial for receptor binding and gating

    by Katarzyna Terejko, Michał A. Michałowski, Anna Dominik, Anna Andrzejczak, Jerzy W. Mozrzymas


  • Open Access

    The C loop at the orthosteric binding site is critically involved in GABAA receptor gating

    by Katarzyna Terejko, Przemysław T. Kaczor, Michał A. Michałowski, Agnieszka Dąbrowska, Jerzy W. Mozrzymas


  • Open Access

    Distinct Modulation of Spontaneous and GABA-Evoked Gating by Flurazepam Shapes Cross-Talk Between Agonist-Free and Liganded GABAA Receptor Activity

    by Magdalena Jatczak-Śliwa, Katarzyna Terejko, Marek Brodzki, Michał A. Michałowski, Marta M. Czyzewska, Joanna M. Nowicka, Anna Andrzejczak, Rakenduvadhana Srinivasan, Jerzy W. Mozrzymas

    GABAA receptors (GABAARs) play a crucial inhibitory role in the CNS. Benzodiazepines (BDZs) are positive modulators of specific subtypes of GABAARs, but the underlying mechanism remains obscure. Early studies demonstrated the major impact of BDZs on binding and more recent investigations indicated gating, but it is unclear which transitions are affected. Moreover, the upregulation of GABAAR spontaneous activity by BDZs indicates their impact on receptor gating but the underlying mechanisms remain unknown. Herein, we investigated the effect of a BDZ (flurazepam) on the spontaneous and GABA-induced activity for wild-type (WT, α1β2γ2) and mutated (at the orthosteric binding site α1F64) GABAARs. Surprisingly, in spite of the localization at the binding site, these mutations increased the spontaneous activity. Flurazepam (FLU) upregulated this activity for mutants and WT receptors to a similar extent by affecting opening/closing transitions. Spontaneous activity affected GABA-evoked currents and is manifested as an overshoot after agonist removal that depended on the modulation by BDZs. We explain the mechanism of this phenomenon as a cross-desensitization of ligand-activated and spontaneously active receptors. Moreover, due to spontaneous activity, FLU-pretreatment and co-application (agonist + FLU) protocols yielded distinct results. We provide also the first evidence that GABAAR may enter the desensitized state in the absence of GABA in a FLU-dependent manner. Based on our data and model simulations, we propose that FLU affects agonist-induced gating by modifying primarily preactivation and desensitization. We conclude that the mechanisms of modulation of spontaneous and ligand-activated GABAAR activity concerns gating but distinct transitions are affected in spontaneous and agonist-evoked activity.